0 CHECKOUT

PRODUCT FILTERS

REGION

CATEGORIES

  • 2
  • 2
  • 2
  • 2
  • 1

PRICE

0
0
0
5

PUBLISHED

0
0
0
5

PRODUCT TYPE

Search for: "Pharmaceutical Industry in United States: Industry Analysis, Forecast, Competition Mapping and Market Trends Assessment, 2011-2015"

Hyperparathyroidism - Analysis and Market Forecasts to 2019

Hyperparathyroidism – Analysis and Market Forecasts to 2019 Summary The global hyperparathyroidism therapeutics market is forecast to grow to reach $2.6 billion by 2019. This moderate growth is primarily...

Published:  October 2012
Price:  From

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia,...

Published:  June 2015
Price:  From

Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Multiple Sclerosis Therapeutics...

Published:  February 2012
Price:  From

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being...

Published:  January 2014
Price:  From

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis Event-Driven Update

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis Event-Driven Update Summary GlobalData has released its new PharmaPoint report, “PharmaPoint: Rheumatoid Arthritis - Global...

Published:  February 2013
Price:  From
Loading Indicator

Our Clients

  • Abbott Laboratories Ltd.
  • Ford Motor Company
  • Honeywell International, Inc.
  • Nike, Inc.
  • Deloitte LLP.
  • IMAX Corporation